BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 8881426)

  • 1. Guillain-Barré syndrome: clinical neurophysiologic studies.
    Cros D; Triggs WJ
    Rev Neurol (Paris); 1996 May; 152(5):339-43. PubMed ID: 8881426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. There are no neurophysiologic features characteristic of "axonal" Guillain-Barré syndrome.
    Cros D; Triggs WJ
    Muscle Nerve; 1994 Jun; 17(6):675-7. PubMed ID: 8196711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axonal form of Guillain-Barré syndrome: evidence for macrophage-associated demyelination.
    Berciano J; Coria F; Montón F; Calleja J; Figols J; LaFarga M
    Muscle Nerve; 1993 Jul; 16(7):744-51. PubMed ID: 8505931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axonal damage in Guillain-Barré syndrome.
    van der Meché FG; Meulstee J; Kleyweg RP
    Muscle Nerve; 1991 Oct; 14(10):997-1002. PubMed ID: 1944413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology of the motor-sensory axonal Guillain-Barré syndrome.
    Griffin JW; Li CY; Ho TW; Tian M; Gao CY; Xue P; Mishu B; Cornblath DR; Macko C; McKhann GM; Asbury AK
    Ann Neurol; 1996 Jan; 39(1):17-28. PubMed ID: 8572662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
    Hadden RD; Cornblath DR; Hughes RA; Zielasek J; Hartung HP; Toyka KV; Swan AV
    Ann Neurol; 1998 Nov; 44(5):780-8. PubMed ID: 9818934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Electrodiagnostic features in inflammatory demyelinating polyneuropathy].
    Baba M; Ozaki I
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1365-7. PubMed ID: 8752397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifocal motor neuropathy with conduction block: Distribution of demyelination and axonal degeneration.
    Vucic S; Black K; Chong PS; Cros D
    Clin Neurophysiol; 2007 Jan; 118(1):124-30. PubMed ID: 17095292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome.
    Kuwabara S; Yuki N; Koga M; Hattori T; Matsuura D; Miyake M; Noda M
    Ann Neurol; 1998 Aug; 44(2):202-8. PubMed ID: 9708542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Guillain-Barré syndrome. Variation on the theme].
    Karlsen B; Vedeler C
    Tidsskr Nor Laegeforen; 1996 Jan; 116(2):242-5. PubMed ID: 8633333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations of nerve conduction measures in axonal and demyelinating polyneuropathies.
    Tankisi H; Pugdahl K; Johnsen B; Fuglsang-Frederiksen A
    Clin Neurophysiol; 2007 Nov; 118(11):2383-92. PubMed ID: 17900975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sequential studies of motor nerve conduction in relation to the disease stages of Guillain-Barré syndrome].
    Kinoshita A; Kawamura J; Hashimoto S; Yamamoto T; Kubori T
    Rinsho Shinkeigaku; 1993 Jun; 33(6):600-5. PubMed ID: 8403678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37 degrees C: diagnostic yield in chronic inflammatory demyelinating polyneuropathy.
    Van Asseldonk JT; Van den Berg LH; Kalmijn S; Wokke JH; Franssen H
    Brain; 2005 Apr; 128(Pt 4):880-91. PubMed ID: 15689367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumor necrosis factor-alpha correlates with electrodiagnostic abnormalities in Guillain-Barré syndrome.
    Sharief MK; Ingram DA; Swash M
    Ann Neurol; 1997 Jul; 42(1):68-73. PubMed ID: 9225687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Guillain-Barré syndrome: morphological lesions and their relations with clinical manifestations].
    Said G
    Rev Neurol (Paris); 1996 May; 152(5):344-8. PubMed ID: 8881427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiologic and immunopathologic correlates in Guillain-Barré syndrome subtypes.
    Uncini A; Yuki N
    Expert Rev Neurother; 2009 Jun; 9(6):869-84. PubMed ID: 19496690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiologic evidence of severe distal nerve segment pathology in the Guillain-Barré syndrome.
    Miller RG; Peterson C; Rosenberg NL
    Muscle Nerve; 1987; 10(6):524-9. PubMed ID: 3627159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [4 cases of Guillain-Barré syndrome with axonal lesions].
    Vallat JM; Hugon J; Tabaraud F; Leboutet MJ; Chazot F; Dumas M
    Rev Neurol (Paris); 1990; 146(6-7):420-4. PubMed ID: 2399405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of proximal conduction block study in diagnosis of inflammatory neuropathies].
    Jaspert A; Claus D; Grehl H; Kerling F; Neundörfer B
    Nervenarzt; 1995 Jun; 66(6):445-54. PubMed ID: 7637830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological changes in the acute "axonal" form of Guillain-Barre syndrome.
    Brown WF; Feasby TE; Hahn AF
    Muscle Nerve; 1993 Feb; 16(2):200-5. PubMed ID: 8429846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.